Don't miss an issue! Renew/subscribe for FREE today.
×

BIOLASE Named Finalist in Medical Devices Category for TechAmerica High-Tech Innovation Awards

Posted on Wednesday, October 9, 2013

 

IRVINE, CA--(Marketwire - May 1, 2012) - BIOLASE Technology, Inc., a leading dental laser manufacturer and distributor, has been named a finalist in the Medical Devices category for the TechAmerica Orange County High-Tech Innovation Awards. Now in its 19th year, this premier business event celebrates excellence and achievement in the region's technology industry, and honors local companies, individuals and products that drive innovation in Orange County. This year's winners will be announced at a dinner on June 14, 2012, at the Hilton in Costa Mesa, CA.

"We received nearly 100 nominations including start-up innovators, high-growth companies and established industry players from across Orange County," said Bob Brunson, director, TechAmerica Orange County. "We congratulate BIOLASE for rising to the finalist rank. This region is home to groundbreaking innovators, including BIOLASE, that continue to influence technology development throughout the rest of the world, and we're excited to help highlight them."

Federico Pignatelli, Chairman and CEO, said, "Providing innovative and disruptive technologies that advance the practice of dentistry and medicine with a truly new and biological surgical device that is leading to enhanced outcomes for far superior and safer patient experiences, continues to be our focus at BIOLASE. We are delighted that our Waterlase iPlus™ all-tissue dental laser system is a finalist for innovative product/technology in the medical devices category. The Waterlase iPlus, our flagship laser, is the most advanced laser ever produced for dentistry and, with its tremendous cutting speed and graphical intuitive user interface, addresses a wide range of clinical procedures and can truly change the practice and economics of dentistry."

For more information, please visit www.techamerica.org/hta19.







Recent Headlines

© 2024 BroadcastMed LLC | Privacy Policy